Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Sep-30-09 | Sep-30-08 | Sep-30-07 | Sep-30-06 | Sep-30-05 | Sep-30-04 | Sep-30-03 | Sep-30-02 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| United States | 2,092.5 | | | | | | | 968.5 |
| Other countries | 1,628.5 | | | | | | | 697.3 |
| Canada | 400.9 | | | | | | | 200.0 |
| Total revenues | 4,121.9 | 5,359.1 | 4,730.5 | 4,367.9 | 3,243.2 | 2,601.0 | 2,142.9 | 1,865.8 |
| Revenue growth [+] | -23.1% | 13.3% | 8.3% | 34.7% | 24.7% | 21.4% | 14.9% | -16.5% |
| United States | | | | | | | | -24.0% |
| Other countries | | | | | | | | -0.1% |
| Canada | | | | | | | | -23.2% |
| Cost of goods sold | 3,523.8 | 4,091.3 | 3,261.0 | 2,895.7 | 2,334.2 | 1,951.0 | 1,665.5 | 1,435.5 |
| Gross profit | 598.1 | 1,267.8 | 1,469.5 | 1,472.1 | 909.0 | 650.0 | 477.3 | 430.3 |
| Gross margin | 14.5% | 23.7% | 31.1% | 33.7% | 28.0% | 25.0% | 22.3% | 23.1% |
| Selling, general and administrative [+] | 267.3 | 279.6 | 249.3 | 235.3 | 203.5 | 161.1 | 143.1 | 130.7 |
| Sales and marketing | 108.2 | 120.7 | 107.1 | 103.3 | 92.3 | 82.1 | 73.7 | 64.1 |
| General and administrative | 159.1 | 159.0 | 142.1 | 132.0 | 111.3 | 79.0 | 69.4 | 66.6 |
| Research and development | 66.3 | 72.0 | 67.5 | 63.9 | 54.2 | 47.3 | 40.8 | 36.5 |
| Other operating expenses | 21.7 | | | 1.2 | 14.2 | 3.2 | 0.2 | |
| EBITDA [+] | 539.0 | 1,180.2 | 1,359.3 | 1,339.2 | 773.9 | 564.1 | 413.5 | 368.0 |
| EBITDA growth | -54.3% | -13.2% | 1.5% | 73.0% | 37.2% | 36.4% | 12.4% | -42.6% |
| EBITDA margin | 13.1% | 22.0% | 28.7% | 30.7% | 23.9% | 21.7% | 19.3% | 19.7% |
| Depreciation and amortization | 296.2 | 264.0 | 206.6 | 167.4 | 136.9 | 125.7 | 120.2 | 104.9 |
| EBIT [+] | 242.8 | 916.2 | 1,152.7 | 1,171.7 | 637.1 | 438.4 | 293.2 | 263.1 |
| EBIT growth | -73.5% | -20.5% | -1.6% | 83.9% | 45.3% | 49.5% | 11.5% | -50.9% |
| EBIT margin | 5.9% | 17.1% | 24.4% | 26.8% | 19.6% | 16.9% | 13.7% | 14.1% |
| Non-recurring items [+] | 13.5 | 2.9 | 0.1 | | | | | 0.2 |
| Asset impairment | 13.5 | 2.9 | 0.1 | | | | | |
| Loss (gain) on sale of assets | 13.5 | 2.9 | 0.1 | | | | | 0.2 |
| Pension curtailments and settlements | 21.7 | | | | | | | |
| Interest expense, net [+] | 26.0 | 26.2 | 31.1 | -0.4 | -0.3 | 10.3 | 13.8 | 7.0 |
| Interest expense | 27.2 | 28.1 | 32.7 | 14.6 | 11.0 | 16.4 | 15.9 | 9.0 |
| Interest income | 1.2 | 1.9 | 1.6 | 14.9 | 11.3 | 6.1 | 2.1 | 2.0 |
| Other income (expense), net [+] | -9.1 | -8.6 | -7.6 | 0.0 | 16.0 | 92.7 | -3.8 | -3.2 |
| Other | -9.1 | -8.6 | -7.6 | | -16.0 | -92.7 | 3.8 | 3.2 |
| Pre-tax income | 194.2 | 878.5 | 1,113.9 | 1,172.1 | 653.3 | 520.7 | 275.7 | 252.7 |
| Income taxes | 28.2 | 258.0 | 360.1 | 367.5 | 200.3 | 159.7 | 87.5 | 86.2 |
| Tax rate | 14.5% | 29.4% | 32.3% | 31.4% | 30.7% | 30.7% | 31.7% | 34.1% |
| Earnings from continuing ops | 166.0 | 620.5 | 753.8 | 804.6 | 453.0 | 361.0 | 188.2 | 166.5 |
| Earnings from discontinued ops | -16.0 | -11.1 | -0.2 | | | | | |
| Net income | 149.9 | 609.4 | 753.6 | 804.6 | 453.0 | 361.0 | 188.2 | 166.5 |
| Net margin | 3.6% | 11.4% | 15.9% | 18.4% | 14.0% | 13.9% | 8.8% | 8.9% |
| |
| Basic EPS [+] | $0.57 | $2.11 | $2.57 | $2.55 | $1.40 | $1.13 | $0.60 | $1.06 |
| Growth | -73.1% | -17.9% | 0.8% | 82.5% | 24.2% | 89.2% | -43.8% | -50.2% |
| Diluted EPS [+] | $0.57 | $2.10 | $2.55 | $2.52 | $1.38 | $1.10 | $0.58 | $1.04 |
| Growth | -73.0% | -17.6% | 0.9% | 83.3% | 24.6% | 89.3% | -43.7% | -50.4% |
| |
| Dividends per share [+] | $0.20 | $0.20 | $0.20 | $200.00 | | | | |
| Growth | 0.0% | 0.0% | -99.9% | | | | | |
| |
| Shares outstanding (basic) [+] | 292.2 | 293.5 | 292.8 | 315.0 | 323.8 | 320.4 | 315.9 | 157.0 |
| Growth | -0.4% | 0.2% | -7.1% | -2.7% | 1.1% | 1.4% | 101.2% | -4.2% |
| Shares outstanding (diluted) [+] | 293.4 | 295.8 | 295.9 | 318.8 | 329.1 | 326.8 | 322.5 | 160.7 |
| Growth | -0.8% | -0.1% | -7.2% | -3.1% | 0.7% | 1.3% | 100.6% | -3.8% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|